These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5586489)

  • 21. A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis of N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and of L-arginine 2-naphthylamide catalysed by cathepsin H.
    Willenbrock F; Brocklehurst K
    Biochem J; 1985 Apr; 227(2):521-8. PubMed ID: 3890831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DEGRADATION OF APURINIC ACID BY CONDENSATION WITH ALDEHYDE REAGENTS.
    LIVINGSTON DC
    Biochim Biophys Acta; 1964 Jul; 87():538-40. PubMed ID: 14211658
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple domains of endopin 2A for serpin cross-class inhibition of papain.
    Hwang SR; Hook VY
    Arch Biochem Biophys; 2007 May; 461(2):219-24. PubMed ID: 17451636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bicyclic carbamates as inhibitors of papain-like cathepsin proteases.
    Epple R; Urbina HD; Russo R; Liu H; Mason D; Bursulaya B; Tumanut C; Li J; Harris JL
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1254-9. PubMed ID: 17196818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An unusual type of enzyme inhibition.
    Sluyterman LA; Wijdenes J
    Biochim Biophys Acta; 1973 Oct; 321(2):697-9. PubMed ID: 4762414
    [No Abstract]   [Full Text] [Related]  

  • 26. Conformational changes of papain induced on interaction with thiol proteinase inhibitors from newborn rat epidermis.
    Takeda A; Kobayashi S; Kaji H; Aoki Y; Samejima T
    J Biochem; 1986 Mar; 99(3):785-91. PubMed ID: 3711044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
    Meara JP; Rich DH
    J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alkyl selenosulphates (seleno Bunte salts). A new class of thiol-blocking reagents.
    Scarf AR; Cole ER; Southwell-Keely PT
    Biochem J; 1982 Feb; 201(2):305-9. PubMed ID: 7082292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the active site of papain with the aid of peptide substrates and inhibitors.
    Berger A; Schechter I
    Philos Trans R Soc Lond B Biol Sci; 1970 Feb; 257(813):249-64. PubMed ID: 4399049
    [No Abstract]   [Full Text] [Related]  

  • 31. Enzyme catalytic promiscuity: The papain-catalyzed Knoevenagel reaction.
    Hu W; Guan Z; Deng X; He YH
    Biochimie; 2012 Mar; 94(3):656-61. PubMed ID: 21963435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular interaction of bovine kininogen and its derivatives with papain.
    Sueyoshi T; Hara A; Shimada T; Kimura M; Morita T; Kato H; Iwanaga S
    J Biochem; 1988 Aug; 104(2):200-6. PubMed ID: 3182763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence energy transfer studies on the active site of papain.
    Henes JB; Briggs MS; Sligar SG; Fruton JS
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):940-3. PubMed ID: 6928689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system.
    Tseng CC; Tseng CP; Levine MJ; Bobek LA
    Arch Biochem Biophys; 2000 Aug; 380(1):133-40. PubMed ID: 10900142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 13C-NMR study of the inhibition of papain by a dipeptide-glyoxal inhibitor.
    Lowther J; Djurdjevic-Pahl A; Hewage C; Malthouse JP
    Biochem J; 2002 Sep; 366(Pt 3):983-7. PubMed ID: 12061892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Q53E- and Q53N--chicken egg white cystatin variants inhibit papain, actinidin and cathepsin B.
    Genenger G; Lenzen S; Mentele R; Assfalg-Machleidt I; Auerswald EA
    Biomed Biochim Acta; 1991; 50(4-6):621-5. PubMed ID: 1801732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a two-state transition in papain that may have no close analogue in ficin. Differences in the disposition of cationic sites and hydrophobic binding areas in the active centres of papain and ficin.
    Brocklehurst K; Malthouse JP
    Biochem J; 1980 Dec; 191(3):707-18. PubMed ID: 7025834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Separation of homologous series of 2,4-dinitrophenyl-osazones by column partition chromatography.
    SCHWARTZ DP
    J Chromatogr; 1962 Oct; 9():187-94. PubMed ID: 13987364
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromatographic identification of carbonyl compounds. 3. Paper chromatographic resolution of aldehyde 2,4-dinitrophenylhydrazone mixtures.
    Ronkainen P
    J Chromatogr; 1967 Apr; 27(2):384-7. PubMed ID: 6058957
    [No Abstract]   [Full Text] [Related]  

  • 40. Papain inhibition by serum.
    Fisher MJ; Jay RE; Haugh LD; Sander EG
    J Appl Physiol; 1976 Aug; 41(2):174-9. PubMed ID: 956098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.